medigraphic.com

2009, Number 3

<< Back Next >>

Enf Infec Microbiol 2009; 29 (3)

Histoplasmosis, the traveler mycosis

Sánchez AMA

Language: Spanish
References: 37
Page: 111-116
PDF size: 301.13 Kb.


ABSTRACT

Histoplasmosis is caused by the fungus Histoplasma capsulatum, this microorganism has been isolated from soil enriched with bird or bat guano, generally from caves. This mycosis is occupational diseases, spelunkers, guano workers and adventure tourists are in risk to acquire the infection. Histoplasmosis could be classified in pulmonary, residual and disseminated disease; spores are inhaled causing strange pneumonia. Generally the infection is asymptomatic, however immunosupred patients (AIDS, chronic diseases) reactivation could be origin disseminated diseases. In recent years, outbreaks of histoplasmosis has been described in travelers to visit caves from Latin-American countries, Mexico is a country with histoplasmosis, is necessary research more about this systemic mycoses in our country.


REFERENCES

  1. Darling ST. “A protozoan general infection producing pseudotubercles in the lungs and focal necroses in the liver, spleen and lymp nodes”. JAMA 46:1283-1285

  2. Kauffman CA. “Histoplasmosis: a Clinical and laboratory update”. Clin Microbiol Rev 2007; 20:115-132

  3. Bonifaz A. Micología Medica Básica. 2ª ed., México: Méndezeditores, 2000; 257-274

  4. Retallack DM, Woods JP. “Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum”. Microb Infect 1999; 817-825

  5. Cano M, Hajjeh RA. “The epidemiology of histoplasmosis: a review.” Semin Respir Infect 2001; 16: 109-118.

  6. Lottenberg O, Waldman RH, Ajello L, et al. “Pulmonary histoplasmosis associated with exploration of a bat cave”. Am J Epidemiol 1979;110:156-161

  7. Eissenberg LG, Goldman WE. “Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis”. Clin Microbiol Rev 1991; 4: 411-21.

  8. Wheat LJ. “Current diagnosis of histoplasmosis”. Trends Microbiol 2003; 11: 488-494.

  9. Stockman, L, KA Clark, JM Hunt, and GD Roberts. “Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum.” J. Clin. Microbiol. 1993; 31: 845–850

  10. Williams B, Fojtasek M, Connolly-Stringfield P, et al. “Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind.” Arch Pathol Lab Med 1994;118: 1205-1208.

  11. Kaufman L, Terry RT, Schubert JH, et al. “Effects of a single histoplasmin skin test on the serological diagnosis of histoplasmosis”. J Bacterial 1967; 94: 798-803.

  12. Martagon-Villamil J, Shrestha N, Sholtis M, et al. “Identification of Histoplasma capsulatum from culture extracts by real-time PCR.” J Clin Microbiol 2003; 41: 1295-1298.

  13. Reid TM, Schafer MP. “Direct detection of Histoplasma capsulatum in soil suspensions by two-stage PCR.” Mol Cell Probes 1999;13: 269-273

  14. Edwards LB, Acquaviva SA, Livesay VT, et al. “An atlas of sensitivity to tuberculin, PPD-B and histoplasmin in the United States.” Annu Rev Respir Dis 1969; 99:1-18

  15. Kurtin PJ, McKinsey DS, Gupta MR, et al. “Histoplasmosis in patients with acquired immunodeficiency syndrome: hematologic and bone marrow manifestations.” Am J Clin Pathol 1990; 093: 367-372

  16. Méndez-Tovar LJ, “Las micosis sistémicas en México”. Gac Med Mex 2008; 144: 128-130

  17. Méndez-Tovar LJ, Lemini-López A, Hernández-Hernández F, et al. “Frecuencia de micosis en tres comunidades de la sierra norte de Puebla”. Gac Med Mex 2003; 139:118-122

  18. Taylor ML, Morales-Quiroz A, Chávez-Cortés CR, et al. “Actualidades inmunológicas y moleculares sobre la epidemiología de la histoplasmosis en Morelos, México”. Gac Med Mex 2000; 136: 441-448.

  19. Taylor ML, Chávez-Tapia CB, Vargas-Yáñez R, et al. “Enviromental conditions favoring bat infections with Histoplasma capsulatum in Mexican shelters”. Am J Trop Med Hyg 1999; 61: 914-919

  20. Arita HT. “Conservation biology of the cave bats of Mexico”. J Mammal 1993; 74: 693-702.

  21. Taylor ML, Granados J, Torriello C. “Biological and sociocultural approaches of histoplasmosis in the State of Guerrero, Mexico”. Mycoses 1996; 39: 375-379.

  22. Taylor ML, Torriello C, Pérez-Mejia A, et al. “Histoplasmosis in the state of Guerrero, México: a biological approach”. Rev Mex Microbiol 1994; 10: 49-53.

  23. Freedman DO, Kozarsky PE, Weld LH, et al. “Geosentinel: the global emerging infections sentinel network of the International Society of Travel Medicine.” J Travel Med, 1999; 6: 94-98.

  24. Ashford DA, Hajjeh RA, Kelley MF, et al. “Outbreak of histoplasmosis among cavers attending the National Speleological Society annual convention, Texas, 1994.” Am J Trop Med Hyg, 1999; 60: 899-903.

  25. Salomón J, Flament-Saillour M, De Truchis P, et al. “An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West Indies.” J Travel Med 2003;10: 87-93.

  26. Nasta P, Donisi A, Cattane A, et al. “Acute histoplamsosis in spelunkers returning from Mato Grosso, Peru.” J Travel Med, 1999; 6:158-260.

  27. Lyon GM, Bravo AV, Espino A, et al. “Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998- 1999.” Am J Trop Med Hyg 2004; 70: 438-442.

  28. Valdez H, Salatan RA. “Bat associated histoplasmosis in returning travelers: case presentation and description of a Cluster.” J Travel Med 1999; 6: 258-260

  29. Gascón J, Torres JM, Luburich P, et al. “Imported Histoplasmosis in Spain.” J Travel Med 2000; 7: 89-91

  30. Buxton JA, Dawar M, Wheat LJ, et al. “Outbreak of histoplasmosis in a school party that visited a cave in Belize: role of antigen testing in diagnosis”. J Travel Med 2002; 9: 48-50.

  31. Hatakeyama S, Kashiyama T, Takechi A, et al. “Case-associated acute pulmonary histoplasmosis in two Japanese returning from Mexico.” Nihon Kokyuki Gakkai Zasshi 2001; 39: 293-297

  32. Morgan J, Cano MV, Feikin DR, et al. “A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001.” Am J Trop Med Hyg 2003; 69: 663-669.

  33. Winberg M, Weeks J, Lance-Parker S, et al. “Severe Histoplasmosis in Travelers to Nicaragua.” Emer Infect Dis 2003; 9: 1322-1325.

  34. García-Vázqez E, Velasco M, Gascón J, et al. “Infección pos Histoplasma capsulatum em um grupo de cooperantes em Guatemala.” Enferm Infecc Microbiol Clin 2005; 23: 274-276.

  35. Nygard K, Brantsaeter A, Feruglio S, et al. “Histoplasmosis among travallers to Central America.” Tidsskr Nor Laegeforen 2006; 126: 2838-2842

  36. Hoenigl M, Schwetz I, Wurm R, et al.“Pulmonary histoplasmosis in three austrian travelers after a journey to Mexico.” Infection 2008; 36: 282-4

  37. Díaz Cuello G, Álvarez Dávila S, García Adame M, et al. “Comportamiento clínico de un brote de histoplasmosis como infección respiratoria aguda en los municipios de Guadalupe y Apodaca 2001.” Respyn 2001; 4. En http://www.cdc.gov/travel/diseases.htm.




2020     |     www.medigraphic.com